Gut hormone co-agonists for the treatment of obesity: from bench to bedside.

Nogueiras, Ruben et al.·Nature metabolism·2023·
RPEP-072282023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Gut hormone co-agonists for the treatment of obesity: from bench to bedside.
Published In:
Nature metabolism, 5(6), 933-944 (2023)
Database ID:
RPEP-07228

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07228·https://rethinkpeptides.com/research/RPEP-07228

APA

Nogueiras, Ruben; Nauck, Michael A; Tschöp, Matthias H. (2023). Gut hormone co-agonists for the treatment of obesity: from bench to bedside.. Nature metabolism, 5(6), 933-944. https://doi.org/10.1038/s42255-023-00812-z

MLA

Nogueiras, Ruben, et al. "Gut hormone co-agonists for the treatment of obesity: from bench to bedside.." Nature metabolism, 2023. https://doi.org/10.1038/s42255-023-00812-z

RethinkPeptides

RethinkPeptides Research Database. "Gut hormone co-agonists for the treatment of obesity: from b..." RPEP-07228. Retrieved from https://rethinkpeptides.com/research/nogueiras-2023-gut-hormone-coagonists-for

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.